Tianjin Lifeon Pharmaceutical Co., Ltd.
2025 Annual Independent Director's Performance Report
In accordance with the "Administrative Measures for Independent Directors of Listed Companies" and the "Independent Director System of Tianjin Lifeon Pharmaceutical Co., Ltd." (hereinafter referred to as the "Company"), I, as an independent director of Tianjin Lifeon Pharmaceutical Co., Ltd., hereby submit this annual performance report to the Board of Directors and the Shareholders' Meeting, explaining the fulfillment of my duties. Your review is requested.
I. Basic Information
(I) Work Experience, Professional Background, and Concurrent Positions
I am Lei Ying, born in 1957, a Chinese national with no permanent residency abroad. I am a member of the Communist Party of China, holding a Master's degree and the professional title of Associate Chief Editor. I have served as a cadre and department head at China National Medicines & Health Products Import & Export Corporation; Deputy Director and Director of the International Cooperation Department of China General Pharmaceutical Corporation; Deputy General Manager of Suzhou Capsule Co., Ltd.; Director of the International Department, Deputy Secretary-General, Secretary-General, and Vice President and Secretary-General of the China Association for Pharmaceutical Manufacturers.
I am currently an independent director of this Company; Executive President of the China Association for Pharmaceutical Manufacturers; member of the editorial board of the "Blue Book of the Pharmaceutical Industry"; and member of the editorial board of "History of Chinese Industry · Pharmaceutical Industry Volume". I have served as an independent director of the Company since December 2021.
I meet the qualifications for independent directors of listed companies as stipulated by relevant laws, regulations, and regulatory rules, and have been filed and reviewed by the Shenzhen Stock Exchange.
(II) Circumstances Not Affecting Independence
I do not hold any positions in the Company other than director. I have no direct or indirect interest relationship with the Company or its major shareholders, nor any other relationship that may affect my independent and objective judgment. I independently fulfill my duties and am not influenced by the Company or its major shareholders or any other entity or individual.
1
In 2025, I conducted a self-assessment of my independence, confirming that I meet the independence requirements for serving as an independent director of the Company as stipulated by applicable regulatory provisions. I submitted the self-assessment results to the Board of Directors. The Board of Directors assessed my independence and found no circumstances that may affect my independent and objective judgment, concluding that I continue to maintain my independence as an independent director.
II. Attendance at Meetings
In 2025, the Company held a total of 8 Board of Directors meetings, of which 2 were held in person. There were 5 Shareholders' Meetings and 3 Independent Director Special Committee meetings. I attended the Company's Board of Directors meetings, Shareholders' Meetings, and Independent Director Special Committee meetings on time. There were no instances of absence or consecutive non-attendance at Board meetings. This year, I diligently reviewed all proposals submitted to the Board of Directors, Shareholders' Meetings, and Independent Director Special Committee meetings. I maintained sufficient communication with the Company's management and offered some reasonable suggestions. I exercised my voting rights with prudence. I believe that the convening and holding of the Company's Board of Directors and Shareholders' Meetings complied with legal procedures, and major operational matters all underwent relevant approval procedures, were legal and valid. Therefore, I voted in favor of all proposals and other matters at the Company's Board of Directors and Independent Director Special Committee meetings in 2025, with no dissenting or abstaining opinions.
III. Issuance of Independent Opinions